The markets closed sharply lower with the Dow plummeting 119 points to 17,865 as crude oil prices fell below $49 per barrel. Nasdaq plunged 64 points to 4,894.
On the upside
Harte-Hanks (NYSE: HHS) stock rose for the fourth day in a row.
Global Blood Therapeutics (Nasdaq: GBT) reported new results from an ongoing Phase 1/2 GBT 440-001 study in sickle cell disease.
The New York Post reported that the proposed merger between Rite Aid (NYSE: RAD) and Walgreens (NYSE: WBA) would likely be approved by regulators.
On the downside
Citigroup downgraded Dynegy (NYSE: DYN) from a Buy rating to a Neutral rating.
Southwestern Energy (NYSE: SWN) entered an agreement to sell 55,000 net acres in West Virginia to Antero Resources.
Falling crude oil prices weighed down shares of SM Energy (NYSE: SM).
In the broad market, declining issues outpaced advancers by a margin of more than 4 to 1 on the NYSE and by 7 to 2 on Nasdaq. The broader S&P 500 tumbled 19 points to 2,096. Bitcoin rose $4 to $572.
